A Phase 3b, Multi-center, Open-label, Trial to Evaluate the Long Term Safety of Titrated Immediate -release Tolvaptan (OPC 41061,30mg to 120mg/day, Split-dose) in Subjects with Autosomal Dominant Polycystic Kidney Disease
Physicians in the Department of Emergency
Medicine have implemented a new protocol for treating
out-of-hospital cardiac arrest patients in Western New York that
has more than doubled the patient survivor rate.
UB internal medicine residents have been selected to receive one
of 30 grants issued nationally by the ACGME’s Back to Bedside
program, which was developed to address some of the challenges
facing medical residents today.